HF
FLNA

HRT Financial’s Filana Therapeutics FLNA Stock Holding History

HRT Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,700
Closed -$102K – 4616
2025
Q4 		$102K Buy
+51,700
New +$166K ﹤0.01% 2788
2022
Q1 		– Sell
-40,300
Closed -$1.76M – 3769
2021
Q4 		$1.76M Buy
40,300
+28,700
+247% +$1.51M 0.01% 734
2021
Q3 		$720K Buy
+11,600
New +$968K ﹤0.01% 1692

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HRT Financial's FLNA Position: Q1 2026 in Review

HRT Financial sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 23,192 shares — an estimated $45K sold.

HRT Financial first reported a position in FLNA in Q2 2022 and held it in 5 quarters. The position peaked at $465K in Q1 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • HRT Financial reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 23,192 Filana Therapeutics shares in Q1 2026, an estimated $45K.
  • HRT Financial first reported a position in Filana Therapeutics in Q2 2022 and held it in 5 quarters.
  • HRT Financial's Filana Therapeutics position peaked at $465K in Q1 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.